ConductScience.org, home

Paper25901475

Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.

Sakamoto K and 10 others. Int J Oncol, 2015. Cited by 46 papers, by iCite.

Cite this record

ConductScience Library. Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA. Papers, record 25901475. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25901475

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2'-deoxy-5-fluorouridine into DNA.
PubMed
Journal
Int J Oncol
PubMed
Year
2015
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
46
iCite
Relative citation ratio, by iCite
1.47
iCite
Revised in PubMed
2022-03-16
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sakamoto KKazuki
2Yokogawa TTatsushi
3Ueno HHiroyuki
4Oguchi KKei
5Kazuno HHiromi
6Ishida KKeiji
7Tanaka NNozomu
8Osada AAkiko
9Yamada YYukari
10Okabe HHiroyuki
11Matsuo KKenichi

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antimetabolites, AntineoplasticMajor topic
Colorectal NeoplasmsMajor topic
DNA, NeoplasmMajor topic
FluorouracilMajor topic
Thymidine KinaseMajor topic
TrifluridineMajor topic
UracilMajor topic
Drug Combinations
Equilibrative Nucleoside Transporter 1
Equilibrative-Nucleoside Transporter 2
HCT116 Cells
Humans
Male
Pyrophosphatases
Pyrrolidines
Substrate Specificity
Thymine

Source PubMed

Download CSV of topics

References32

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12971045Isolation and characterization of a mutant of L1210 murine leukemia deficient in nitrobenzylthioinosine-insensitive nucleoside transport.J Biol Chem1988https://conductscience.org/library/papers/2971045PubMed
2285077Human deoxyuridine triphosphate nucleotidohydrolase. Purification and characterization of the deoxyuridine triphosphate nucleotidohydrolase from acute lymphocytic leukemia.J Biol Chem1979https://conductscience.org/library/papers/285077PubMed
36305486Biochemical strategy of cancer cells and the design of chemotherapy: G. H. A. Clowes Memorial Lecture.Cancer Res1983https://conductscience.org/library/papers/6305486PubMed
47999767Mechanism-based inhibition of thymidylate synthase by 5-(trifluoromethyl)-2'-deoxyuridine 5'-monophosphate.Biochemistry1994https://conductscience.org/library/papers/7999767PubMed
57494863Mammalian deoxyribonucleoside kinases.Pharmacol Ther1995https://conductscience.org/library/papers/7494863PubMed
69771948Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells.Cancer Chemother Pharmacol1998https://conductscience.org/library/papers/9771948PubMed
814186018SYNTHESES OF 5-TRIFLUOROMETHYLURACIL AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE.J Med Chem1964https://conductscience.org/library/papers/14186018PubMed
915571283Intracellular thymidylate synthase inhibition by trifluorothymidine in FM3A cells.Nucleosides Nucleotides Nucleic Acids2004https://conductscience.org/library/papers/15571283PubMed
1015711180Determinants of trifluorothymidine sensitivity and metabolism in colon and lung cancer cells.Anticancer Drugs2005https://conductscience.org/library/papers/15711180PubMed
1117441963Therapeutic potential of the dual-targeted TAS-102 formulation in the treatment of gastrointestinal malignancies.Cancer Sci2007https://conductscience.org/library/papers/17441963PubMed
1220372850Immunohistochemical characterization of pyrimidine synthetic enzymes, thymidine kinase-1 and thymidylate synthase, in various types of cancer.Oncol Rep2010https://conductscience.org/library/papers/20372850PubMed
1320371715Trifluorothymidine resistance is associated with decreased thymidine kinase and equilibrative nucleoside transporter expression or increased secretory phospholipase A2.Mol Cancer Ther2010https://conductscience.org/library/papers/20371715PubMed
1419417150XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center.Mol Cancer Ther2009https://conductscience.org/library/papers/19417150PubMed
1521319870Treatment of viral conjunctivitis with antiviral drugs.Drugs2011https://conductscience.org/library/papers/21319870PubMed
1620560137Identification of potential pharmacogenomic markers of clinical efficacy of 5-fluorouracil in colorectal cancer.Int J Cancer2011https://conductscience.org/library/papers/20560137PubMed
1722068047Thymidine kinase and cancer monitoring.Cancer Lett2012https://conductscience.org/library/papers/22068047PubMed
1822172489Inhibition of dUTPase induces synthetic lethality with thymidylate synthase-targeted therapies in non-small cell lung cancer.Mol Cancer Ther2012https://conductscience.org/library/papers/22172489PubMed
1922951287TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial.Lancet Oncol2012https://conductscience.org/library/papers/22951287PubMed
2023604282Heterogeneity of tumor-induced gene expression changes in the human metabolic network.Nat Biotechnol2013https://conductscience.org/library/papers/23604282PubMed
2125230742Repeated oral dosing of TAS-102 confers high trifluridine incorporation into DNA and sustained antitumor activity in mouse models.Oncol Rep2014https://conductscience.org/library/papers/25230742PubMed

See all 32 referencesDownload CSV of references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.

PMIDTitleJournalYearIn PapersSource
42592050Nucleotide Metabolism in Health and Disease.MedComm (2020)2026https://conductscience.org/library/papers/42592050PubMed
42168481Trifluridine/tipiracil enhances radiation-induced abscopal effects and augments PD-1 blockade in gastric cancer.Sci Rep2026https://conductscience.org/library/papers/42168481PubMed
40807411Incorporation and Repair of Epigenetic Intermediates as Potential Chemotherapy Agents.Molecules2025https://conductscience.org/library/papers/40807411PubMed
40673011Total neoadjuvant therapy integrating long-course radiotherapy with trifluridine/tipiracil for locally advanced rectal cancer: a single-arm, multicenter phase 2 trial.EClinicalMedicine2025https://conductscience.org/library/papers/40673011PubMed
40358665Impact of renal function on non-hematologic toxicities in mCRC patients treated with TAS-102: a post-hoc analysis of the JASCC-CINV2001 study.Support Care Cancer2025https://conductscience.org/library/papers/40358665PubMed
39747494Renal impairment as a risk factor for chemotherapy induced neutropenia in the treatment of trifluridine/thymidine phosphorylase inhibitor plus bevacizumab.Sci Rep2025https://conductscience.org/library/papers/39747494PubMed
39244627TAS-102, Irinotecan, and bevacizumab in pre-treated metastatic colorectal cancer (TABAsCO), a phase II clinical trial.Br J Cancer2024https://conductscience.org/library/papers/39244627PubMed
38630197The emerging emetogenicity of trifluridine/tipiracil (TAS‑102) from patient self-reporting: a multicenter, prospective, observational study.Support Care Cancer2024https://conductscience.org/library/papers/38630197PubMed
38202064A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal Cancer.J Clin Med2023https://conductscience.org/library/papers/38202064PubMed
37940878Prognostic impact of severe neutropenia in colorectal cancer patients treated with TAS-102 and bevacizumab, addressing immortal-time bias.BMC Cancer2023https://conductscience.org/library/papers/37940878PubMed
36291880External Validation of the Colon Life Nomogram for Predicting 12-Week Mortality in Dutch Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil in Daily Practice.Cancers (Basel)2022https://conductscience.org/library/papers/36291880PubMed
35599264
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen.
Med Oncol2022https://conductscience.org/library/papers/35599264PubMed
35280098Severe pancytopenia caused by trifluridine/tipiracil in patients with metastatic colorectal cancer and an impaired renal function: A case report.Clin Case Rep2022https://conductscience.org/library/papers/35280098PubMed
34884270Biomarkers of Trifluridine-Tipiracil Efficacy.J Clin Med2021https://conductscience.org/library/papers/34884270PubMed
33895696Issues and limitations of available biomarkers for fluoropyrimidine-based chemotherapy toxicity, a narrative review of the literature.ESMO Open2021https://conductscience.org/library/papers/33895696PubMed
33780084Monitoring FTD in the peripheral blood mononuclear cells of elderly patients with metastatic colorectal cancer administered FTD plus bevacizumab as first-line treatment.Cancer Sci2021https://conductscience.org/library/papers/33780084PubMed
32457882β-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest.Front Bioeng Biotechnol2020https://conductscience.org/library/papers/32457882PubMed
32322913Detection of trifluridine in tumors of patients with metastatic colorectal cancer treated with trifluridine/tipiracil.Cancer Chemother Pharmacol2020https://conductscience.org/library/papers/32322913PubMed
32162797Bevacizumab in Combination with TAS-102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study.Oncologist2020https://conductscience.org/library/papers/32162797PubMed
31619711CD44/CD133-Positive Colorectal Cancer Stem Cells are Sensitive to Trifluridine Exposure.Sci Rep2019https://conductscience.org/library/papers/31619711PubMed

See all 34 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25901475

GET https://conductscience.org/api/papers/v1/25901475/references?page=2